SCHEDULE: Activist Investor Kent Lake Reduces Quanterix Stake to 4.5% While Resubmitting Board Nominations
Schedule 13D Amendment
Activist investor Kent Lake Partners LP has reduced its beneficial ownership in Quanterix Corp to 4.5% through recent share sales, while simultaneously re-nominating three individuals for election to the Board of Directors at the rescheduled 2025 annual meeting.
Summary
- Kent Lake Partners LP, along with Kent Lake PR LLC and Benjamin Natter, collectively beneficially own 2,089,500 shares of Quanterix Corp common stock, representing approximately 4.5% of the outstanding shares as of July 11, 2025.
- The aggregate purchase price for the currently held 2,089,500 shares by Kent Lake Partners is approximately $16,846,942, including brokerage commissions.
- Kent Lake Partners LP sold a total of 387,472 shares of Quanterix Common Stock between June 18, 2025, and June 25, 2025, at prices ranging from $6.1095 to $6.4860 per share.
- As of July 11, 2025, the Reporting Persons ceased to beneficially own more than 5% of Quanterix Corp's outstanding shares.
- Kent Lake resubmitted its nomination of Alexander G. Dickinson, Bruce Felt, and Hakan Sakul for election to the Board of Directors at the 2025 annual meeting of stockholders.
- The 2025 annual meeting of stockholders has been rescheduled to September 23, 2025.
Sentiment
Score: 4
Explanation: The filing indicates a reduction in the activist investor's beneficial ownership below 5% due to recent share sales, which can be perceived negatively. While the activist continues to pursue board nominations, the overall sentiment is slightly negative due to the divestment and the delay in the annual meeting.
Negatives
- Kent Lake Partners LP, an activist investor, reduced its beneficial ownership in Quanterix Corp from above 5% to 4.5% as of July 11, 2025, through significant share sales.
- The divestment by an activist investor can signal a lack of confidence or a shift in their investment strategy, potentially leading to negative market perception.
Future Outlook
Kent Lake intends to continue pursuing the election of its nominated directors, Alexander G. Dickinson, Bruce Felt, and Hakan Sakul, at the rescheduled 2025 annual meeting of stockholders on September 23, 2025.
Industry Context
The document does not provide specific industry context or analysis of broader industry trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Nomination | Kent Lake resubmitted nominations for Alexander G. Dickinson, Bruce Felt, and Hakan Sakul for election to the Board of Directors at the 2025 annual meeting of stockholders. | 2025-09-23 | Potential for new independent directors to join the board, potentially influencing strategic direction and oversight. |
Stakeholder Impact
- Shareholders are directly impacted by the activist's reduced stake, which may influence market perception and share price.
- Shareholders will vote on the nominated directors at the upcoming annual meeting, potentially altering the composition and strategic direction of the Board.
Next Steps
- The 2025 annual meeting of stockholders is scheduled for September 23, 2025, where the nominated directors will be considered for election.
Key Dates
| Date | Description |
|---|---|
| 2025-02-28 | Kent Lake delivered initial letter nominating directors for the 2025 annual meeting. |
| 2025-06-18 | Kent Lake Partners LP sold 117,472 shares of Common Stock at $6.4860. |
| 2025-06-20 | Kent Lake Partners LP sold 90,845 shares of Common Stock at $6.1877. |
| 2025-06-23 | Kent Lake Partners LP sold 83,398 shares of Common Stock at $6.1497. |
| 2025-06-24 | Kent Lake Partners LP sold 69,463 shares of Common Stock at $6.1484. |
| 2025-06-25 | Kent Lake Partners LP sold 26,294 shares of Common Stock at $6.1095. |
| 2025-07-11 | Date of event requiring filing of this statement; Reporting Persons ceased to beneficially own more than 5% of outstanding shares; Issuer's Post-Effective Amendment No. 3 on Form S-8 filed; Kent Lake resubmitted director nominations. |
| 2025-07-14 | Kent Lake Partners LP effected a short sale of 211,500 Akoya Biosciences, Inc. shares delivered pursuant to the closing of the merger with Quanterix Corp. |
| 2025-07-15 | Date of signing of Amendment No. 2 to Schedule 13D. |
| 2025-09-23 | Rescheduled date for the 2025 annual meeting of stockholders. |
Keywords
Quanterix Corp, Schedule 13D, beneficial ownership, activist investor, board nomination, corporate governance, share sales, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.